Aster DM Quality Care Limited (ASTERDM) Gross Profit 2022–2026

Name: Aster DM Quality Care Limited (ASTERDM) gross profit history 2022-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Aster DM Quality Care Limited annual gross profit for fiscal 2026 was ₹35.3 billion, an increase of 12.2% from ₹31.5 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

ASTERDM Annual Gross Profit

Gross Profit (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Gross Profit	₹35.3B	₹31.5B	₹27.2B	₹21.7B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ASTERDM Quarterly Gross Profit

Gross Profit (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Gross Profit	₹10.2B	₹9.2B	₹9.2B	₹8.3B	₹7.8B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Gross Profit at Comparable Companies

APOLLOHOSP Gross Profit — Apollo Hospitals Enterprise Limited
MAXHEALTH Gross Profit — Max Healthcare Institute Limited
MANIPALHOS Gross Profit — Manipal Health Enterprises Limited
FORTIS Gross Profit — Fortis Healthcare Limited
MEDANTA Gross Profit — Global Health Limited
NH Gross Profit — Narayana Hrudayalaya Limited

More ASTERDM metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow

All ASTERDM financial statements → Interactive ASTERDM charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.